ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[IL1RN, TNF, TNFSF11, MAP4K1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, FZD8, CD40LG, PKN1]
GO:0060244;negative regulation of cell proliferation involved in contact inhibition;6.0;1.0;0.8231203125901445;9.628524252492122;46.9815665635761;8.390779266560578;0.001572430752218078;0.7522251544931926;[PAK1, DACH1, FAP]
GO:0061052;negative regulation of cell growth involved in cardiac muscle cell development;10.0;1.0;0.9152410118609203;9.628524252492122;1870.595370074125;8.16763571524637;0.0626071436098452;0.8329342821725234;[PAK1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, HEPACAM2, TUBE1, BRCA1, UXT, FES, NUP62]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, KITLG, SFRP2, NASP, MSH2, KIT]
GO:0090331;negative regulation of platelet aggregation;10.0;0.9326813400603323;0.8815816818910864;9.601125278304007;548.6740902153413;7.379178354882098;0.01836362802488484;0.7926125360964777;[CEACAM1, PRKCD, CD9]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCD, CCL2, DLL1]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[NRP1, PLXND1, CTSZ, PHB2, HOXA11, HHEX, HOXA5, PAX2, SFRP2, COL4A1, ENG, EPHA2, PAK1, TGFB1, EGF, VDR, PPP1CA, BMP2]
GO:0051490;negative regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.67846133901236;0.005818533269131697;0.8400575416471059;[PRKCD]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP, EPB41L3, TLN1]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[PHB2, AKT1, TNFSF11, CYP1B1, SFRP4, BTK, SIK1, PRKCQ, BEX1, TWIST1, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, JUP, ID1, EZH2, CD40, CD36, HAVCR2, SYK, ANXA3, NFAM1, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, TLR6, SGK1, TLR4, TLR2, FLNA, NLRP12, CD40LG, TNF, CLU, PYCARD, MEN1, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, WFS1, NFKB1, NFKBIA, IL6, COPS5, JMY, CCDC22, MYD88, CREBZF, ITGB2, TNFAIP3, MYOCD, CHUK, IRAK3, TRAF1, XCL1, LTF, NLRC4, NOD2, KLF4]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, AQP1, PLAU, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, SUV39H1, ALAD, MYOCD, ADSL, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, PAK1, E2F1, TEK]
GO:0007406;negative regulation of neuroblast proliferation;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;502.0817198454759;8.390779266560578;0.016804223319016428;0.8041048419030481;[TGFB1, CTNNA1]
GO:0002758;innate immune response-activating signal transduction;9.0;0.6324783794010864;0.7124798148808322;8.79372655486915;406.8866713069129;4.647174912757396;0.013618130714412242;0.6338973663344365;[CLEC10A, ICAM2, ICAM3, PRKACB, CD180, PRKCD, CLEC4D, BTK, S100A8, CARD11, LY96, KLRK1, CLEC7A, S100A14, CD14, MAP2K6, LYN, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, TNFAIP3, CTSS, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, IRAK3, TLR1, HCK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, COLEC12, UNC93B1, NOD2, HSPD1, PAK1, FYN, CARD9]
GO:2000753;positive regulation of glucosylceramide catabolic process;8.0;1.0;0.875;9.628524252492122;623.5788865307586;9.777073627680469;0.0208706241476218;0.875;[PRKCD]
GO:2000755;positive regulation of sphingomyelin catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;1040.6474307865747;9.777073627680469;0.034829532986543094;0.9152410118609203;[PRKCD]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[PAK1, PSRC1, FES]
GO:2001045;negative regulation of integrin-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;187.41437209568753;9.083926447120524;0.006272590372058239;0.8154717862087246;[CTNNA1]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, IL6]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, ECT2, TGFB1, JUP, PRKCD, MAPK14, IFNG]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, FES, NTF3, STAP1, TEK]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, CDH5, DUSP10, GHSR, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, GATA3, NT5E, NLRP3, ELANE, KLF4, NFKB1, NLRP12, TEK, FCGR2B]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, BLM, MGST1, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, CD3G, CD3E, CD3D, ALAD, EMILIN1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[PRKCD, MELK, CYP1B1]
GO:0045773;positive regulation of axon extension;11.0;0.8933024483968273;0.8790801765280758;9.582004236857228;1257.908905926367;6.113511981550823;0.04210107903683872;0.7450742393735527;[CYFIP1, NRP1, FN1, PAK1, CXCL12, MAP1B]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[CELSR1, ARHGAP6, ARHGAP4, EPS8, PAK1, ARHGDIA, PDPN, ARHGDIB, RAC2, EPS8L1, CHUK, RHOG, RHOH, COL1A2, BCL6, AGTR1, RHOU]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, PRKCD, TSC2, SLA2, PTPRE, IL1B, PRKCQ]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[NRP1, PAK1, STMN1]
GO:0002522;leukocyte migration involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;38.08781428465786;9.083926447120524;0.0012747648673000812;0.7876727335416686;[HCK]
GO:0006605;protein targeting;9.0;0.7192862368539868;0.7558837436072825;9.182237149863703;93.4429707305496;4.015022244900292;0.0031274521371376313;0.6015690495021188;[HOMER3, HSD17B4, SCARB2, CLU, LAMP2, HGS, SLC27A2, EHHADH, NUP54, NLGN1, VPS41]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[NRP1, ARHGEF10L, CTGF, PAK1, TPM1, NOX4]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, EPB41L3, SFN, FN1, NRP1, CDKN1A, ARHGAP4, ESM1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, IGFBP5, S100A8, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, CYR61, TCHP, MYOCD, DCC, DNM2, PSRC1, NDUFS3, FBP1, TAF9, RAB21, SEMA4B]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, BTK, AGTR1, GATA3, ADAMTS12, PLA2G7, CD19, S100A12, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, ANXA1, FCER1G, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QA, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, IL17A, PROS1, TNF, CLU, CDH5, IGHG1, GHSR, ADCYAP1, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, NOD2, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, CD6, TEK, FCGR2B]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PPP1R15A, PDGFRB, TGFB1, PPP1R12A, FCRL3, PRKCD, LILRB2, DLC1]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, PCNA, C5AR1, ATIC, HMOX1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, LCP1, EZH2]
GO:0071803;positive regulation of podosome assembly;8.0;1.0;0.875;9.628524252492122;306.3544197830862;7.379178354882098;0.01025340672906212;0.7523715242355574;[LCP1, TNF]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[JUN, CHL1, TNC, CTNNA1, JAM3]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[, NUP107, F11R, AKT1, SEH1L, NUP85, EPB41L3, NUP88, JUP, PLK1, COL1A1, EHD3, EZH2, LRRC4, MMP12, CENPA, FLNA, DMD, CSE1L, TNF, CLU, CDH1, RUVBL2, LAMP2, CD177, RAB32, PKP3, SLC27A2, LIN7A, NACC2, REEP1, PLEKHF1, LRRK2, ITGB2, ITGAL, HHEX, ITGB7, ITGA4, PPP1R15A, NLGN1, TSPAN33, TSPAN15, DNAJA3, VPS41, PAQR3, GOLPH3L, ESCO2, TSPAN5, ID1, CD24, NRP1, PTPRK, BRCA2, TRAM2, XPO1, FCER1G, SYK, RAB33B, MIS12, HSD17B4, CTNNA1, RANBP2, RANBP1, RPA1, RAMP1, SCARB2, BUB1B, CELSR1, TTC7B, TSC2, ATP1B1, HGS, VCL, STIL, NUP155, CAV1, TNFAIP3, NUP62, NUP133, AXIN2, EHHADH, NUP54, SHANK3, AURKB, HSPD1, NUP35, RAN]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, EPS8, ACTN1, PAWR, ACTN4, SORBS1, MARCKS, ZYX, LCP1]
GO:0071801;regulation of podosome assembly;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;64.45443428147517;7.069023426578259;0.002157231910176139;0.7124295520356204;[HCK, GSN, LCP1, TNF]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[, ITGAM, ITGB2, PAK1, FYN]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP1, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, HPSE, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, PDGFRA, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, PRKCD, HMGA1, MAPK14, SIRT1]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[STMN1, EPHB1, MEF2A, MAP1B, SDC2, EPB41L3, NCKAP1L, GP5, PTK2, NR4A2, LRFN4, OGN, NRP1, LRRK2, RAC2, DCC, PAX2, DNM2, SGK1, DSCAML1, SHANK3, NLGN1, LRP2, PAK1, NTF3, SLITRK6, FYN, LINGO1, WEE1]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FMR1, XPO1, AKT1, SLC11A1, PRKCD, AXIN2, E2F1, TNFSF13, MAPK14, MYD88]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:1904754;positive regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;244.58802208207217;7.212124270218933;0.008186140984158152;0.7650689957573628;[DOCK5, PAK1, DOCK4, NR4A3, IGFBP5]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, PAK1, KLRK1, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, CLEC4D, CARD11]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, PTK2, ZYX, PLP1, LAT]
GO:0032703;negative regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.7325511899570465;0.002184000309729388;0.6674232935401965;[LAG3, XCL1, TNFAIP3, HOMER3, GATA3, CD34, HAVCR2]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, PRKACB, MAP2K2, SLC11A1, F2R, PRKCD, PRKAR1B, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKAR2B, PDGFC, NCKAP1L, ECT2, DRD4, MAP2K6, TGFB2, TNFRSF10B, BMP2, CSPG4, LRRK2, ITGB3, GHR, MAP4K1, SYK, DUSP6, MDFIC, IL1B, KIT, CHI3L1, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CCL19, EGF, MAPK14, CD40LG, PKN1]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, GATA3, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0051149;positive regulation of muscle cell differentiation;6.0;0.7090535922965819;0.6776471087384355;8.848365694942547;114.55096530066652;5.346256828837156;0.0038339177194376536;0.5965281354432446;[CXCL9, SMARCD3, CTNNA1, MEF2A, MEF2C, MYOCD, TGFB1, TNFSF14, FLT3LG, MAPK14, SIRT1, KIT, ENG]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2R1A, NTF3, CAV1, PRKCD, SFRP2, PTPN6]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, IFI6, TNF, IL1B, CTNNA1, AKT1, SNAI2, FYN, PF4]
GO:2001241;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;424.359905324836;7.292166977892469;0.01420294413210246;0.7881627702307852;[PPP2R1A, CTNNA1, INHBA, PPP1CA]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:1900163;positive regulation of phospholipid scramblase activity;9.0;1.0;0.896240625180289;9.628524252492122;406.95467434623936;9.777073627680469;0.013620406714939737;0.896240625180289;[PRKCD]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP1, MMP2, LAMC1, MMP8, MMP9, CTSS, MMP12, TIMP2, MMP19, CTSG, TIMP1, LCP1, ELANE]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, SLA2, GRAP2, FYN, CSK, LYN, SYK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[INHBA, ADCYAP1, KIT, CTNNA1, MMP19]
GO:0030913;paranodal junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;88.99224575364705;7.8311634786251565;0.00297849037755313;0.7236063770733796;[EPB41L3, CD9]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[FCER1G, PRKCD, EXO1, INPP5D, TLR8, FCGR2B, IL13RA2, HLA-DQB1]
GO:2000146;negative regulation of cell motility;6.0;0.5781283279524737;0.6121844765663813;8.01908634005802;116.39406446339459;4.247644540169047;0.0038956045897326065;0.5403450519100613;[IL1RN, SERPINE1, SPINT2, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, FBLN1, GATA3, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TMEFF2, ENG, CX3CR1, LRP1, THBS1, SPOCK3, CTNNA1, CCL2, CCL21, TIE1, PODN, KLF4, DLC1]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[SERPINE1, SPINT2, MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, CLDN7, PADI2, PDGFA, FPR2, GATA3, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, TACR3, SIRT1, F3, TMEFF2, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, PKN1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, IGFBP5, F2R, TPM1, ADAM9, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, CXCL12, PTPRC, PLXNB2, ITGB3, CYR61, DUSP10, EMILIN1, ITGA4, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4B, TIE1, KLF4, IL1RN, SPARC, LGALS3, IL1R1, ACTN4, MIF, EREG, BTC, SFRP2, PFN1, EPHA2, TWIST1, CCR1, TNFSF14, PPBP, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, PTPRK, RAC2, CTSH, CCR7, CCR6, CCR2, GAB1, CEACAM1, CEACAM6, IL1B, KIT, SGK1, GNAI2, PAK1, CXCR2, PDPN, CTNNA1, MPP1, PODN, DLC1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, VCL, C5AR1, FBLN1, STAP1, TGFB2, TGFB1, SELP, IL6, BMP2, NR4A3, FES, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, ARAP3, MMP9, DCN, FGR, IFNG, LAMA3, THBS1, SPOCK3, EGF, LAMB1, MAPK14, TEK]
GO:2000304;positive regulation of ceramide biosynthetic process;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;909.7864372675522;7.57984905034425;0.03044973330070948;0.7838744581139225;[PRKCD, TNF, CYR61]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[PAK1, TGFB1, AKT1, THBS1, SLC8A1]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, ITGAM, PRKCD, ITGB2, FPR2, GNAI2, CD177]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[PYCARD, PPP2R1A, PRKCD, MAL, ATF3, S100A8, NACC2, TP53BP2, SFN, TNFSF12, CAV1, INHBA, ITM2C, PLEKHF1, CTSH, TIMP3, YWHAH, MMP9, SIRT1, TFDP1, LCK, THBS1, E2F1, CTNNA1, GSN, BIK, G0S2, PPP1CA, LTBR]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, CSF2RB, MAP2K6, LYN, LIF, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, KIF16B, FES, HBEGF]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, VRK1, MELK, BTK, SIK1, BLK, CSF1R, LYN, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, AURKB, PAK1, FYN, CSK, CAMK4, TEK]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[NUP62, MCCC2, CHRNB4, CLDN3, NUP54, NLGN1, CTNNA1, RRM1, JUP, GCH1, COL1A1, COL1A2, P2RX1]
GO:0007216;G-protein coupled glutamate receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;54.172554706560106;7.069023426578259;0.0018131066538945874;0.7124295520356204;[GRM5, GRIK3, HOMER3]
GO:0002286;T cell activation involved in immune response;6.0;0.6997970393407541;0.6730188322605215;8.890925309361343;82.05045983278045;5.845247994956144;0.002746155049983451;0.6220465668840318;[IFNA5, IFNA4, IFNA7, IFNA2, GATA3, CD1C, ITGAL, IFNA8, IFNA21, IFNA14, FCER1G, IFNA16, SLC11A1, LILRB1, CLEC4D, LCP1, IL18R1, IFNA10]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, SERPINE1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, PDGFA, FPR2, GNS, S100A12, NCKAP1L, ELANE, LYN, JUP, FUCA1, FN1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, TIMP3, TIMP1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, FLNA, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, ATP8A1, PROS1, ITGA2B, HP, F13A1, APEH, CLU, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB3, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, VWF, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, CCL8, TTR, CCL5, PCDH7, FCGR2A, P2RX1, IMPDH2, VPS41, PTPN6, MNDA, FOLR3, SPARC, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CD14, CCR1, PRG2, NBEAL2, PPBP, BST1, TF, VNN1, ORM1, ECM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, TLR2, LILRA3, STX11, PAK1, CXCR1, CXCR2, CD58, CCT8, LHFPL2, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, APLP2, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MYH10, MGAM, TGFB2, TGFB1, SYT2, SELP, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, SYNGR3, MMP9, FGR, MMRN1, CHI3L1, LTF, CLEC12A, RETN, THBS1, EGF, MAPK14, CD9, S100P, PTX3]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[, IL5RA, TNF, FGF5, TNFSF11, KCNH1, MEN1, PDGFRB, MEF2A, KCNH2, PDGFRA, MEF2C, MAP2K2, PAQR3, EREG, BTC, PDGFA, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, LYN, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, NOD2, IL2RG, PAK1, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRRK2, CTSZ, RUVBL2, STMN1, AKT1, ITGA4, PRKCD, AES, SLPI, ADRB2, AURKB, EPB41L5, CCL23, CAV1, EIF2S1, PPP1CA, ID1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, STXBP2, FGR, FES, RAC2, HMOX1, IL13RA2]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[TNF, RACGAP1, EPB41L3, NCKAP1L, TLN1, LLGL2]
GO:0023021;termination of signal transduction;7.0;0.8653626801206646;0.7836007053175329;9.434368238051164;144.8699869040881;8.67846133901236;0.004848668087156246;0.7947362817240173;[PRKCD]
GO:0010737;protein kinase A signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;7.474488534686424;8.845336528452411E-4;0.7053660038532718;[LCP1]
GO:0070885;negative regulation of calcineurin-NFAT signaling cascade;10.0;1.0;0.9152410118609203;9.628524252492122;339.10982455209705;7.292166977892469;0.011349700648730492;0.7881627702307852;[HOMER3]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCD, VRK1, AURKB, CCNA2, CHEK1, PKN1]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, EPHA3, LYN, FZD1, SYT2, FN1, CXCL12, FES, PLXNB2, EZH2, ROBO2, NRP1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, FKBP1B]
GO:1904385;cellular response to angiotensin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;7.379178354882098;0.015486127626965131;0.7523715242355574;[PRKCD, CDC6, SLC30A10, NFKB1]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BLM, PCNA, FMR1, BRCA1, NACC2, PRKCD, SIRT1]
GO:0031032;actomyosin structure organization;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.01253927882412;5.16195311083921;0.001071430880247358;0.5871028347338303;[ITGB5, LMOD1, F11R, EPB41L5, CNN1, RACGAP1, EPB41L3, MYH14, MYOZ2, MYH10, PDGFRB, MEF2A, PDGFRA, TPM1, SORBS1, KRT19, ZYX]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0002175;protein localization to paranode region of axon;5.0;1.0;0.7902410118609202;9.628524252492122;40.92839637806193;8.390779266560578;0.0013698365936084043;0.7193458537639684;[EPB41L3]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, STAB1, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, CD4]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CDH1, CTNNA1, BRCA1]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[ITGB5, IFI30, CD36, FCGR1B, FCER1G, CHUK]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0071205;protein localization to juxtaparanode region of axon;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.92839637806193;8.16763571524637;0.0013698365936084043;0.7079342821725234;[EPB41L3]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, DAPK1, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0032079;positive regulation of endodeoxyribonuclease activity;9.0;1.0;0.896240625180289;9.628524252492122;975.1149925155983;8.390779266560578;0.03263622125297896;0.8253454670833372;[PRKCD, AKT1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCD, VRK1, PRKCQ, PLK2, PLK1, CLK1, LRRK2, MAP4K1, CHUK, SYK, SGK1, AURKB, MAPK14, CAMK4, PKN1]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SIRPG, TNF, SIRPB1, PYCARD, CD36, FCER1G, SYK, SLC11A1, DNM2, FGR, HCK, IL1B, PRTN3, TLR2, STAP1, CCL2, NCKAP1L, CSK, TGFB1, AZU1, PTX3, FCGR2B]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, PKP3, TSPAN33, EPB41L3, FLNA, TSPAN5, JUP, TSPAN15, EHD3, RAMP1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCD, CAD, VRK1, CLK1, PKN1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, CSF1R, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, PTK2, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, DLC1]
GO:2001275;positive regulation of glucose import in response to insulin stimulus;9.0;1.0;0.896240625180289;9.628524252492122;210.7203529833852;6.832634648514029;0.00705262057834843;0.7456618788553018;[PAK1, SORBS1]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, FOXO1, PAK1, SORBS1]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[JUN, IGFBP5, MMP2, MMP9, TNF, GNAI2, PAK1, NR4A3]
GO:0043297;apical junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;7.697632086000634;0.001878987018571015;0.7167775754447168;[CTNNA1, VCL]
GO:0033157;regulation of intracellular protein transport;7.0;0.5976175254657065;0.6497281279900537;8.424551448166186;91.13662740810908;4.352123610199067;0.0030502609017097797;0.5734871690772262;[, CHRM1, CDH1, PRKCD, IFI27, SFN, ECT2, BARD1, TGFB1, JUP, FZD5, PKIG, CDKN1A, ITGAM, LRRK2, ITGB2, XPO1, NUP62, RAC2, CD36, SIRT1, IFNG, MDFIC, IL1B, NUP54, RHOU, LCP1, PTGS2, PAK1, ABLIM3, FYN, MAPK14, NUCB1]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, FOXO1, AQP1, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, IL6, EZH2]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, ANTXR1, PAK1, FLNA, CXADR, ANXA1, GAB1, KIT]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, HLA-DPA1, IFNGR1, PRKCD, HCK, IFNG, HLA-DQB1, PTAFR, NCAM1, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[HMGB2, MPL, TNF, TNFSF11, HOXA5, FOS, IFNG, INPP5D, NCKAP1L, CCR1, JUN, JAG1, LIF, INHBA, TMEM64, MAPK14, CD4, FES, ACIN1, PF4, IL17A]
GO:0043299;leukocyte degranulation;8.0;0.811012628672052;0.780506314336026;9.223059144383958;48.80626136022181;3.5624655292582776;0.0016335016449431083;0.5571846528378576;[CDA, CYFIP1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, TGFA, PDGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, VAV1, HCK, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, TSC2, KIF16B, COL4A1, BLK, CSF1R, CUL5, RASGRP4, FOXO1, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B]
GO:0030837;negative regulation of actin filament polymerization;11.0;0.8436909121759173;0.8542744084176208;9.536150932361107;433.7598075732239;5.8067817141283475;0.014517550400993206;0.7293880392331511;[LMOD1, EPS8, SPTA1, SPTAN1, GSN, PRKCD, PFN1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLU, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, LILRB1, CD40LG, GRINA, MAD2L1, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, GATA3, CD1D, LY9, KLRK1, SLAMF7, S100A12, CD14, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, CSF1R, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, NOD2, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, LMOD1, PYCARD, CCR7, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, JMY]
GO:0045880;positive regulation of smoothened signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;187.6437959822434;6.343086423195323;0.006280268983073171;0.6753050999230941;[PRRX1, POR, CTNNA1]
GO:0033148;positive regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;233.77170011230152;7.379178354882098;0.007824128421887714;0.7523715242355574;[, YAP1, PAK1, SKP2]
GO:0016264;gap junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;7.8311634786251565;0.001878987018571015;0.7236063770733796;[GJC1, GJB2, CTNNA1]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[STAT4, IL12RB1, IL12RB2, MIF, IFNG, LCP1]
